MSLN and colorectal carcinoma: The study population comprised 7446 patients representing the low and high MSLN expressing quartiles of the 14,892 total CRC patient samples in the Caris Life Sciences database, of which 6847 patients were assigned to the “MSS cohort” according to MSI status.